ElevateBio Executive and Leadership Team

November, 2026

Leadership Overview

ElevateBio has 4 executives leading key functions including corporate strategy, operational scaling, financial management, and advanced technology development.

Focused on accelerating the next generation of genetic medicines, ElevateBio builds and operates a diverse portfolio of cell and gene therapy companies to transform patient outcomes through scientific innovation.

Leadership Roles at ElevateBio

  • Chief Executive Officer & Board Member - Christopher Murphy
  • Chief Financial Officer - Bhakti Bhargava
  • Chief Operating Officer - Steve Falcone
  • Chief Technology Officer, Elevatebio Basecamp - Michael Paglia
  • Christopher Murphy - Chief Executive Officer & Board Member

    Christopher Murphy, the Chief Executive Officer & Board Member at ElevateBio, directs the overarching corporate strategy and long-term vision for the entire portfolio of cell and gene therapy companies. Murphy manages high-level partnerships with leading scientists and inventors to ensure the rapid advancement of therapeutic candidates from concept to clinical application. By aligning board objectives with operational execution, the Chief Executive Officer & Board Member maintains a focus on sustainable growth and market leadership within the biotechnology sector. Christopher Murphy oversees the integration of various subsidiary entities, ensuring consistent adherence to the mission of creating transformative genetic medicines. This leadership role involves constant evaluation of the competitive landscape across North American markets to identify new opportunities for expansion. Through rigorous oversight of capital allocation and strategic planning, the Chief Executive Officer & Board Member secures the necessary resources to drive innovation and deliver significant value to stakeholders and patients alike.
    Christopher Murphy

    Bhakti Bhargava - Chief Financial Officer

    Bhakti Bhargava, the Chief Financial Officer at ElevateBio, directs the financial planning, reporting, and capital management strategies essential for sustaining a complex portfolio of cell and gene therapy companies. Bhargava oversees the allocation of investment funds to high-potential research projects, ensuring that financial resources align with the long-term goals of the organization. By managing investor relations and financial risk, the Chief Financial Officer provides the stability necessary for sustained innovation in the biotechnology space. Bhakti Bhargava evaluates the economic viability of new partnerships and potential acquisitions to expand the company's market footprint. This leadership role involves close collaboration with the Board to maintain fiscal discipline while pursuing aggressive growth targets. Through the implementation of robust financial controls and data-driven forecasting, the Chief Financial Officer supports the overall mission of delivering advanced genetic medicines. Bhargava ensures that the company remains well-positioned to navigate the capital-intensive nature of the life sciences industry while maximizing shareholder value.
    Bhakti Bhargava

    Steve Falcone - Chief Operating Officer

    Steve Falcone, the Chief Operating Officer at ElevateBio, manages the internal infrastructure and cross-functional workflows required to support a growing portfolio of biotechnology ventures. Falcone optimizes operational efficiency across all subsidiary companies, ensuring that research and development timelines remain on track for critical milestones. By streamlining internal processes, the Chief Operating Officer facilitates seamless collaboration between scientific teams and administrative departments. Steve Falcone monitors the performance of various operational units to maintain high standards of quality and compliance in gene therapy manufacturing. This role requires constant coordination with other C-suite leaders to align resource distribution with the broader corporate strategy. Falcone drives the implementation of scalable systems that allow the organization to adapt to the evolving demands of the global cell therapy market. Through meticulous management of daily operations, the Chief Operating Officer ensures that the company maintains a competitive edge while fostering an environment conducive to rapid scientific discovery and commercial success.
    Steve Falcone

    Michael Paglia - Chief Technology Officer, Elevatebio Basecamp

    Michael Paglia, the Chief Technology Officer, Elevatebio Basecamp at ElevateBio, architects the technical infrastructure and manufacturing capabilities required to support the development of complex cell and gene therapies. Paglia leads the technological advancement of the Basecamp platform, ensuring that all portfolio companies have access to state-of-the-art tools and processes for therapeutic production. By overseeing the integration of cutting-edge laboratory technologies, the Chief Technology Officer, Elevatebio Basecamp drives the efficiency of the entire research-to-manufacturing pipeline. Michael Paglia manages the technical teams responsible for scaling production processes to meet clinical and commercial requirements. This role involves constant interaction with scientific inventors to translate novel concepts into scalable, high-quality manufacturing solutions. Through the continuous improvement of technical workflows, the Chief Technology Officer, Elevatebio Basecamp ensures that the organization remains at the forefront of biotechnology innovation. Paglia maintains a focus on technical excellence to accelerate the delivery of life-changing treatments to patients across global markets.

    Explore Leadership Teams in Holding Companies & Conglomerates

    Frequently Asked Questions Regarding ElevateBio Top Executives and Leadership Team

    Who leads ElevateBio?
    ElevateBio is led by Christopher Murphy (Chief Executive Officer & Board Member), along with executives such as Bhakti Bhargava (Chief Financial Officer) and Steve Falcone (Chief Operating Officer).
    Who is part of ElevateBio’s executive team?
    The executive team of ElevateBio includes leaders such as Christopher Murphy (Chief Executive Officer & Board Member), Bhakti Bhargava (Chief Financial Officer), Steve Falcone (Chief Operating Officer) and other senior executives.
    How many executives does ElevateBio have?
    ElevateBio has 4 executives leading key business areas.
    What roles are included in ElevateBio’s leadership team?
    The leadership team of ElevateBio includes roles such as Chief Executive Officer & Board Member, Chief Financial Officer, Chief Operating Officer, Chief Technology Officer, Elevatebio Basecamp.